DXCM
DexCom IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$25.98B
P/E Ratio
31.87
EPS
$2.09
Beta
1.53
52W High
$89.98
52W Low
$54.11
50-Day MA
$70.43
200-Day MA
$72.55
Dividend Yield
—
Profit Margin
17.90%
Forward P/E
26.81
PEG Ratio
0.98
About DexCom Inc
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Fundamentals
| Revenue (TTM) | $4.66B |
| Gross Profit (TTM) | $2.80B |
| EBITDA | $1.16B |
| Operating Margin | 25.60% |
| Return on Equity | 34.50% |
| Return on Assets | 8.89% |
| Revenue/Share (TTM) | $11.95 |
| Book Value | $7.14 |
| Price-to-Book | 9.38 |
| Price-to-Sales (TTM) | 5.57 |
| EV/Revenue | 5.4 |
| EV/EBITDA | 18.52 |
| Quarterly Earnings Growth (YoY) | 78.00% |
| Quarterly Revenue Growth (YoY) | 13.10% |
| Shares Outstanding | $384.87M |
| Float | $382.94M |
| % Insiders | 0.39% |
| % Institutions | 100.98% |
Historical Volatility
HV 10-Day
24.66%
HV 20-Day
26.85%
HV 30-Day
35.65%
HV 60-Day
31.36%
HV Rank
23.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($87.44 target)
5
Strong Buy20
Buy3
Hold1
Strong SellData last updated: 3/25/2026